Company intelligence / Profile preview

GenericsWeb

Sydney, New South Wales, Australia

Ownership: Private
Development stage: Other

Overview

GenericsWeb is a specialist provider of patent and regulatory intelligence for the global pharmaceutical industry, with a primary focus on the generic drug sector. The company is best known for its "Pipeline Developer" database, which tracks patent expiries, supplementary protection certificates (SPCs), and regulatory exclusivities to help firms identify market entry opportunities. By providing high-quality, verified intellectual property data, GenericsWeb enables pharmaceutical companies to manage litigation risks and optimize their product launch strategies. Founded in 1999 and headquartered in Australia, the company was acquired by Thomson Reuters in 2013 to enhance its life sciences intellectual property portfolio.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on GenericsWeb.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenericsWeb.

Explore the full profile